Dr. Birgit Vogel and Dr. C. Michael Gibson Discuss: Sex-Specific Outcomes In High-Risk Patients Receiving Ticagrelor With Or Without Aspirin After Percutaneous Coronary Intervention: Results From The Twilight Study May 17, 2021
Dr. Robert Rosenson and Dr. C. Michael Gibson Discuss: A Phase 2 Trial Of The Efficacy And Safety Of Evinacumab In Patients With Severe Hypertriglyceridemia May 15, 2021 Disclosures: TBD
Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: Relationship Between Omega-3 Fatty Acid Levels And Major Adverse Cardiovascular Outcomes In Patients With High Cardiovascular Risk May 15, 2021 Disclosures: TBD
Dr. Jean-Philippe Collet, Dr. Gilles Montalescot and Dr. C. Michael Gibson Discuss: Oral Anti-xa Anticoagulation After Trans-aortic Valve Implantation For Aortic Stenosis: The Randomized Atlantis Trial and the 4d Computed Tomography Substudy May 15, 2021 Disclosures: TBD
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: ACC 2021 Wrap-Up – May 15, 2021 May 15, 2021 Disclosures: TBD
Dr. C. Michael Gibson and Dr. Renato Lopes Discuss: Randomized Clinical Trial To Evaluate A Routine Full Anticoagulation Strategy In Patients With Coronavirus Infection (SARS-CoV-2) Admitted To Hospital: The Coalition ACTION Trial May 15, 2021
Dr. Kreton Mavromatis and Dr. C. Michael Gibson Discuss: Impact Of Completeness Of Revascularization On Quality-of-life In Patients With Stable Ischemic Heart Disease: Insights From The ISCHEMIA Trial May 15, 2021 Disclosures: TBD
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: Effects Of Interleukin-6 Inhibition With Ziltivekimab On Biomarkers Of Inflammation Among Patients At High Risk For Atherosclerotic Events May 15, 2021 Disclosures: TBD
Dr. Carolyn Lam reviews the Lancet Commission Report on the Global Cardiovascular Burden in Women and how to improve it May 15, 2021 Disclosures: TBD
Dr. Dalane Kitzman and Dr. C. Michael Gibson Discuss: A Novel Physical Rehabilitation Intervention For Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Trial May 15, 2021
